Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Hermann

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Journal of Medicinal Chemistry|May 1, 2012
A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluationVerena Hugenberg, Hans-Jörg Breyholz, Burkhard Riemann, et al.
Nature Communications|August 8, 2014
Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activityThomas Vogl, Michel Eisenblätter, Tom Völler, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 24, 2016
Corrigendum: Labeling and Selective Inactivation of Gram-Positive Bacteria Employing Bimodal Photoprobes with Dual ReadoutsAnzhela Galstyan, Desiree Block, Silke Niemann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 2, 2016
Labeling and Selective Inactivation of Gram-Positive Bacteria Employing Bimodal Photoprobes with Dual ReadoutsAnzhela Galstyan, Desiree Block, Silke Niemann, et al.
Nuclear Medicine and Biology|May 16, 2016
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stabilityVerena Hugenberg, Sven Hermann, Fabian Galla, et al.
Angiogenesis|October 19, 2013
Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imagingThorsten Persigehl, Janine Ring, Christoph Bremer, et al.
Cell Reports|August 23, 2023
S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritisMeike von Wulffen, Veronika Luehrmann, Stefanie Robeck, et al.
Scientific Reports|May 18, 2017
FGF23/FGFR4-mediated left ventricular hypertrophy is reversibleAlexander Grabner, Karla Schramm, Neerupma Silswal, et al.
Science Translational Medicine|November 11, 2016
Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrierHanna Gerwien, Sven Hermann, Xueli Zhang, et al.
Theranostics|March 4, 2017
A specific dietary intervention to restore brain structure and function after ischemic strokeMaximilian Wiesmann, Bastian Zinnhardt, Dirk Reinhardt, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|May 1, 2012
A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluationVerena Hugenberg, Hans-Jörg Breyholz, Burkhard Riemann, et al.
Nature Communications|August 8, 2014
Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activityThomas Vogl, Michel Eisenblätter, Tom Völler, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 24, 2016
Corrigendum: Labeling and Selective Inactivation of Gram-Positive Bacteria Employing Bimodal Photoprobes with Dual ReadoutsAnzhela Galstyan, Desiree Block, Silke Niemann, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 2, 2016
Labeling and Selective Inactivation of Gram-Positive Bacteria Employing Bimodal Photoprobes with Dual ReadoutsAnzhela Galstyan, Desiree Block, Silke Niemann, et al.
Nuclear Medicine and Biology|May 16, 2016
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stabilityVerena Hugenberg, Sven Hermann, Fabian Galla, et al.
Angiogenesis|October 19, 2013
Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imagingThorsten Persigehl, Janine Ring, Christoph Bremer, et al.
Cell Reports|August 23, 2023
S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritisMeike von Wulffen, Veronika Luehrmann, Stefanie Robeck, et al.
Scientific Reports|May 18, 2017
FGF23/FGFR4-mediated left ventricular hypertrophy is reversibleAlexander Grabner, Karla Schramm, Neerupma Silswal, et al.
Science Translational Medicine|November 11, 2016
Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrierHanna Gerwien, Sven Hermann, Xueli Zhang, et al.
Theranostics|March 4, 2017
A specific dietary intervention to restore brain structure and function after ischemic strokeMaximilian Wiesmann, Bastian Zinnhardt, Dirk Reinhardt, et al.
Pageof 13